ERBB2 and breast carcinoma: RRBP1 expression is markedly associated with breast cancer histological grade, human EGFR 2 (HER-2) status, p53 status and molecular subtypes; furthermore, in patients with HER-2+ breast cancer, increased RRBP1 expression is associated with worse overall survival (OS) (4).